Comparison of severity scoring of atopic dermatitis values and serum levels of eosinophil cationic protein and mast cell tryptase for routine evaluation of atopic dermatitis

Acta Dermato-Venereologica

Volumn 80, Issue 4, 2000, Pages 284-286

  Amon, U ^a   Memmel, U ^a   Stoll, R ^a   Amon, S ^a  

^a PsoriSol Ctr for Dermatol/Allergy   (Germany)

Author keywords

Eosinophils; Outcomes measures; Quality assurance

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; TRYPTASE;

ADOLESCENT; ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME BLOOD LEVEL; EOSINOPHIL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MAST CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SCORING SYSTEM;

EID: 0033796327     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/000155500750012180     Document Type: Article

References (29)

1. Levels of soluble interleukin 2 receptors correlate with the severity of atopic dermatitis
2. Eosinophil cationic protein in sera of patients with atopic dermatitis
3. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis
4. Soluble CD14 but not interleukin 6 is a new marker for clinical activity in atopic dermatitis
5. Levels of soluble ICAM-1 in atopic dermatitis
6. Soluble E-selectin in sera of patients with atopic dermatitis and psoriasis - Correlation with disease activity
7. Soluble CD30 in pediatric patients with atopic dermatitis
8. Severity scoring of atopic dermatitis: The SCORAD index
9. Elevated serum levels of soluble adhesion molecules ICAM-1 and ELAM-1 in patients with severe atopic eczema and influence of UVA1 treatment
10. Serum soluble IL-2 receptor (SIL-2R) and eosinophil cationic protein (ECP) levels in atopic dermatitis
11. Eosinophil involvement in atopic dermatitis as reflected by elevated serum levels of eosinophil cationic protein
12. Eosinophil cationic protein, myeloperoxidase and tryptase in children with asthma and atopic dermatitis
13. Plasma histamine concentrations in atopic dermatitis
14. Increased plasma tumor necrosis factor-alpha concentrations in atopic dermatitis
15. Investigations on plasma levels of mast cell mediators in acute atopic dermatitis
16. Mast cells of psoriatic and atopic dermatitis skin are positive for TNF-alpha and their degranulation is associated with expression of ICAM-1 in the epidermis
17. Diagnostic features of atopic dermatitis
18. Atopic dermatitis
19. Prozessoptimierung psychologischer Trainings in der Hautklinik im Rahmen des Total Quality Management
20. Psychodermatology: An overview
21. Soluble E-selectin, other markers of inflammation and disease severity in children with atopic dermatitis
22. Measurement of disease activity and outcome in atopic dermatitis
23. Quality assurance in dermatology - The development of a framework
24. Soluble interleukin 2 receptor in atopic eczema
25. Soluble E-selectin as a marker of disease activity in atopic dermatitis
26. Soluble E-selectin correlates with disease activity in cyclosporin A-treated patients with atopic dermatitis
27. Regulation and function of mast cell proteases in inflammation
28. Mast cells in atopic dermatitis
29. The potential clinical utility of serum alpha-protryptase levels